Arbutus Biopharma Corporation (ABUS)

Last Closing Price: 4.11 (2026-11-18)

EBITDA Margin (Quarterly)

EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues

Arbutus Biopharma Corporation (ABUS) EBITDA Margin data is not available.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$0.30M
$59.12M
--
$0.30M
$10.79M
$-10.49M
$69.61M
$59.12M
$59.12M
--
--
--
--
$-10.49M
$-10.48M
198.68M
199.63M
$0.30
$0.30
Balance Sheet Financials
$339.57M
--
$0.13M
$339.70M
$241.93M
--
$12.02M
$253.95M
$85.75M
$85.75M
$85.75M
199.28M
Cash Flow Statement Financials
$225.68M
$1.04M
$19.47M
$18.01M
$264.19M
$246.18M
$4.17M
--
--
Fundamental Metrics & Ratios
1.40
--
--
--
--
100.00%
-3509.70%
-3509.70%
EBITDA Margin
--
19770.90%
19770.90%
$225.68M
--
--
--
0.00
--
0.38
238.39
--
--
--
--
$0.43
$1.13
$1.13